Effects of a dietary chitosan and calcium supplement on Ca and P metabolism in cats

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 117, Issue 7-8, 2004, Pages 310-315

  Wagner, Elisabeth ^a,b   Schwendenwein, Ilse ^b   Zentek, Jürgen ^a  

^a Institut fur Ernahrung   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Cat; Chitosan; Chronic renal failure; Digestibility; Phosphorus binder; Plasma phosphate; Plasma urea

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CHELATING AGENT; CHITOSAN; PHOSPHATE; PHOSPHORUS;

AGING; ANIMAL; ANIMAL DISEASE; ANIMAL FOOD; ARTICLE; BLOOD; CALCIUM INTAKE; CAT; CAT DISEASE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DIGESTION; FEMALE; MALE; METABOLISM; PHYSIOLOGY; UREA NITROGEN BLOOD LEVEL;

AGING; ANIMAL FEED; ANIMALS; BLOOD UREA NITROGEN; CALCIUM; CALCIUM CARBONATE; CALCIUM, DIETARY; CAT DISEASES; CATS; CHELATING AGENTS; CHITOSAN; DIETARY SUPPLEMENTS; DIGESTION; FEMALE; KIDNEY FAILURE, CHRONIC; MALE; PHOSPHATES; PHOSPHORUS;

FELIS CATUS; FRAXINUS;

EID: 3342889026     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Barber, P. J., J. M. Rawlings, P. J. Markwell, J. Elliott (1999): Effect of dietary phosphate restriction on renal secondary hyperparathyroidism in cat. J. Small Anim. Pract. 40, 62-70.
2. Baxter, J., F. Shimizu, Y. Takiguchi, M. Wada, T. Yamaguchi (2000): Effect of iron (III) chitosan intake on the reduction of serum phosphorus in rats. J. Pharm. Pharmacol. 52, 863-874.
3. Bernkop-Schnürch, A. (2000): Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm. 194, 1-13.
4. Elliott, J., J. M. Rawlings, P. J. Markwell, P. J. Barber (2000): Survival of cats with naturally occurring chronic renal failure: effect of dietary management. J. Small Anim. Pract. 41, 235-242.
5. Graff L., D. Burnel (1995): Reduction of dietary phosphorus absorption by oral phosphorus binders. Res. Com. Mol. Path. Pharm. 90, 389-401.
6. Hejazi, R., M. Amiji (2003): Chitosan-based gastrointestinal delivery systems. J. Control. Release 89, 151-165.
7. Janssen M. J., A. van der Kuy, P. M. Ter Wee, W. P. van Boven (1996): Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Clin. Nephrol. 45, 111-119.
8. Jing, S. B., L. Li, D. Ji. Y. Takiguchi, T. Yamaguchi (1997): Effect of chitosan on renal function in patients with chronic renal failure. J. Pharm. Pharmacol. 49, 721-723.
9. Lau, A. H., J. M. Kuk, K. L. Franson (1998): Phosphate-binding capacities of calcium and aluminum formulations. Int. J. Artif. Organs 21, 19-22.
10. Nagano, N., H. Yoshimoto, T. Nishitoba, H. Sato, S. Miyata, M. Kusaka, S. B. Jing, T. Yamaguchi (1995): Pharmacological properties of chitosan-coated dialdehyde cellulose (chitosan DAC). A newly developed oral adsorbent (II). Effect of chitosan DAC on rats with chronic renal failure induced by adriamycin. Nippon Yakurigaku Zasshi. 106, 123-133.
11. Naumann, K., R. Bassler (1993): Die chemische Untersuchung von Futtermitteln. 3. Aufl., VDLUFA-Verlag, Darmstadt.
12. Polzin, D. J., C. A. Osborne, J. W. Bartges, K. M. James, J. A. Churchill (1995): Chronic renal failure. In: Ettinger ST. J., E. C. Feldman: Textbook of veterinary internal medicine diseases of dog and cat. Philadelphia: W. B. Saunders, 1734.
13. Polzin, D. J., C. A. Osborne, S. Ross, F. Jacob (2000): Dietary management of feline chronic renal failure: where are we now? In what direction are we headed? J. Feline Med. Surg. 2, 75-82.
14. Razdan, A., D. Pettersson (1996): Hypolipidaemic, gastrointestinal and related responses of broiler chickens to chitosans of different viscosity. Br. J. Nutr. 76, 387-397.
15. Slatopolsky, E., C. Weerts, T. Stokes, D. Windus, J. Delmez (1986): Alternative phosphate binders in dialysis patients: calcium carbonate. Semin. Nephrol. 6, 35-41.
16. Takamoto, S., T. Onishi, S. Morimoto, S. Imanaka, H. Tsuchiya, T. Yokokawa, N. Iida, Y. Kumahara (1985): Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminium hydroxide administration. Nephron. 40, 286-291.
17. Wada, M., Y. Nishimura, Y. Watanabe, T. Takita, S. Innami (1997): Acceleration effect of chitosan intake on urinary calcium excretion by rats. Biosc. - Biotech. and Biochem. 61, 1206-1208.
18. Weaver, C. M., D. G. Schulze, L. W. Peck, H. M. Magnusen, B. R. Martin, S. E. Gruenhagen (1999): Phosphate-binding capacity of ferrihydrite versus calcium acetate in rats. Am. J. Kidney Dis. 34, 324-327.
19. Yamaguchi, T., J. G. Baxter, N. Maebashi, T. Asano (1999): Oral phosphate binders: phosphate binding capacity of iron (III) hydroxide complexes containing saccharides and their effect on the urinary excretion of calcium and phosphate in rats. Ren. Fail. 21, 453-468.
20. Zhang, H., S. H. Neau (2002): In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials 23, 2761-2766.